0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global recombinant therapeutic antibodies proteins market research report 2019.Your search for "" gave back 1533064 results.
Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H1 2018 Summary Lymphocyte Activation Gene 3 Protein (Protein...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas...
Catalog:
Global Markets Direct
June 2022
Price: USD 3,500.00
Colitis - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis -...
Catalog:
Global Markets Direct
September 2019
Price: USD 2,000.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
Catalog:
La Merie Publishing
March 2014
Price: USD 1,514.00
Recombinant plasma protein therapeutics market is driven by various factors such as shift from use of plasma-derived proteins to recombinant...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The biological product manufacturing is a complex process which produces products derived from recombinant DNA technology to develop a series of...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Lymphocyte Activation Gene 3 Protein (Protein FDC or CD223 or LAG3) - Pipeline Review, H2 2018 Summary Lymphocyte Activation Gene 3 Protein (Protein...
Catalog:
Global Markets Direct
October 2018
Price: USD 3,500.00
78 kda Glucose Regulated Protein - Pipeline Review, H2 2019 Summary 78 kda Glucose Regulated Protein (Endoplasmic Reticulum Lumenal Ca(2+) Binding...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Recombinant Therapeutic Protein are produced by using a technique called recombinant DNA or recombinant RNA to produce proteins. The method can be...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
In the 1970s, recombinant DNA technology hardly opened a new era of pharmaceutical biotechnology. Therefore, the definition of protein therapeutics...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
T Cell Specific Surface Glycoprotein CD28 - Pipeline Review, H2 2019 Summary T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) pipeline Target...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline...
Catalog:
Global Markets Direct
March 2019
Price: USD 3,500.00
For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
T Cell Surface Glycoprotein CD4 (T Cell Surface Antigen T4/Leu 3 or CD4) - Pipeline Review, H1 2018 Summary T Cell Surface Glycoprotein CD4 (T Cell...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
